Expectations Rising for BP plc (BP) Numbers; Macrocure (MCUR) Upward Breakout Session


Shares of BP plc (NYSE:BP) spend Monday’s trading session in negative territory ahead of the company’s release of its quarterly earnings report, finally closing at $31.79, down $0.36 (or -1.12%). 8,228,047 of its shares exchanged hands during the day.

The British oil giant expects to report its first quarter 2016 financial results on Tuesday, April 26 before the market open.

BP, which operates as an integrated oil and gas company worldwide, has 3.07B Shares Outstanding, Market Capitalization (intraday) of $97.55B and BP stock 52-week range is between $27.01 and $43.85 per share



The price of Macrocure Ltd. (Nasdaq:MCUR) stock soared to touch the $2.00 mark in intraday trading Monday, finishing the regular session at $1.66, up $0.57 (or +52.29%) with a total volume of 7,153,421 shares traded, representing a large increase in activity versus its average volume (3m) of 50,405.

There appears to be no relevant recent information from the biotechnology company that may explain the stock’s rally.

Macrocure, focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, has 17.06M Shares Outstanding, Market Capitalization (intraday) of $28.32M and MCUR stock one-year range is from $0.75 to $16.10 per share.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/